MedTrace Logo

Efficacy of 5% Nanochitosan Paste in the Treatment of Oral Candidosis

NCT07793331 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-08-28

No results posted yet for this study

Summary

This study is designed to survey the therapeutic effect of a low molecular weight 5% nanochitosan paste against oral candidosis (denture stomatitis) and compare its efficacy with a standard Nystatin ointment.

Conditions

  • Denture Stomatitis
  • Oral Candidosis

Interventions

DRUG

5% Nanochitosan Paste

A 5% paste of low molecular weight chitosan nanoparticles prepared via the ionic gelation method using sodium tripolyphosphate.

DRUG

Nystatin Ointment

Standard commercial antifungal Nystatin ointment utilized as the active reference treatment.

Sponsors & Collaborators

  • Kerman University of Medical Sciences

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2016-12-01
Completion
2016-12-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07793331 on ClinicalTrials.gov